SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-251816
Filing Date
2018-08-17
Accepted
2018-08-17 17:19:58
Documents
7
Period of Report
2018-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d579758d8k.htm 8-K 19582
2 EX-1.1 d579758dex11.htm EX-1.1 177149
3 EX-5.1 d579758dex51.htm EX-5.1 9477
4 EX-99.1 d579758dex991.htm EX-99.1 8551
5 GRAPHIC g579758g0817221826825.jpg GRAPHIC 2021
6 GRAPHIC g579758g0817221827184.jpg GRAPHIC 6753
7 GRAPHIC g579758g0817225458571.jpg GRAPHIC 3823
  Complete submission text file 0001193125-18-251816.txt   233756
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617- 531-2130
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 181026551
SIC: 2834 Pharmaceutical Preparations